IPO registrations (S-1, F-1) · Underwriters
Delivery of
- Deals
- 10 priced offerings as an underwriter; 8 initial public offerings
- Proceeds of those deals
- $1,708,083,600
- Years
- 2010–2020
- Named in
- 19 prospectuses and registration statements in all, including offerings not yet priced or withdrawn
- Named as
- Delivery of; Delivery of the
Deals by year
| Year | Deals | As lead | Proceeds of deals |
|---|---|---|---|
| 2020 | 1 | 0 | $161,118,630 |
| 2018 | 4 | 0 | $224,170,000 |
| 2016 | 2 | 0 | $1,113,222,212 |
| 2014 | 2 | 0 | $169,142,855 |
| 2010 | 1 | 0 | $40,429,903 |
Deals 10
| Priced | Company | Role | Price | Range | Shares | Proceeds | Listing | Kind | Syndicate | Prospectus |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-10-06 | Benitec Biopharma Inc. CA | Syndicate | $60.42 | 2,666,644 | $161,118,630 | Nasdaq BNTC | Offering | 2 | 424B4 ↗ | |
| 2018-11-27 | Ability Inc. L3 | Syndicate | $3.25 | 360,000 | $1,170,000 | Nasdaq ABIL | IPO | 3 | 424B4 ↗ | |
| 2018-10-22 | LogicBio Therapeutics, Inc. MA | Syndicate | $10.00 | 7,000,000 | $70,000,000 | Nasdaq LOGC | IPO | 5 | 424B4 ↗ | |
| 2018-06-13 | MICROVISION, INC. WA | Syndicate | $1.25 | 14,400,000 | $18,000,000 | Nasdaq MVIS | Offering | 4 | 424B4 ↗ | |
| 2018-05-04 | Construction Partners, Inc. AL | Syndicate | $12.00 | 11,250,000 | $135,000,000 | Nasdaq ROAD | IPO | 6 | 424B4 ↗ | |
| 2016-06-03 | NantHealth, Inc. NC | Syndicate | $14.00 | 6,500,000 | $91,000,000 | Nasdaq NH | IPO | 6 | 424B4 ↗ | |
| 2016-05-27 | US Foods Holding Corp. IL | Syndicate | $23.00 | 44,444,444 | $1,022,222,212 | NYSE USFD | IPO | 17 | 424B4 ↗ | |
| 2014-07-28 | El Pollo Loco Holdings, Inc. CA | Syndicate | $15.00 | 7,142,857 | $107,142,855 | Nasdaq LOCO | IPO | 6 | 424B4 ↗ | |
| 2014-05-02 | SCYNEXIS INC NJ | Syndicate | $10.00 | 6,200,000 | $62,000,000 | Nasdaq SCYX | IPO | 6 | 424B4 ↗ | |
| 2010-07-22 | GREEN DOT CORP UT | Syndicate | $8.87 | 4,558,050 | $40,429,903 | IPO | 6 | 424B4 ↗ |
“Offering” is a priced registered offering that the cover page does not describe as an initial public offering: a follow-on, a resale, or a small company’s best-efforts deal.
Registrations in progress or never priced 1
| Filed | Company | Role | Range | Shares | Listing | Status | Document |
|---|---|---|---|---|---|---|---|
| 2021-01-19 | DECIPHER BIOSCIENCES, INC. | Syndicate | - | Nasdaq DECI | Pending | S-1 ↗ |
Works alongside
| Firm | Deals together | Of which that firm led |
|---|---|---|
| H.C. Wainwright | 3 | 2 |
| Jefferies | 3 | 3 |
| Morgan Stanley | 3 | 3 |
| Baird | 2 | 1 |
| Canaccord Genuity | 2 | 1 |
| Deutsche Bank | 2 | 0 |
| J.P. Morgan | 2 | 1 |
| William Blair | 2 | 1 |
| Barclays | 1 | 1 |
| BMO Capital Markets | 1 | 0 |
| BofA Securities | 1 | 0 |
| C Anaccord G Enuity | 1 | 0 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Offering terms are read from the cover pages of the registrant's final prospectus (424B4, 424B1) and its latest registration statement before pricing: the price range, the final price, shares offered, gross proceeds (the cover's total, else price times shares), exchange and ticker, and the underwriters named on the cover and in the underwriting table (loader/s1_terms.py). Underwriter names are normalised, so Goldman, Sachs & Co. of 1999 and Goldman Sachs & Co. LLC of 2024 are one firm.